Will residuals be paid? It’s complicated. By Jonathan Handel Ryan Kavanaugh - H 2015 Contrary to a published report, there is no “promise” that $8 million of Relativity funds will go to pay residuals.
At 36 months, the disease-free survival and molecular residual disease event-free rate was 86 vs 36% for patients in the osimertinib and placebo groups. HealthDay News — For patients with resected ...
Phase I clinical trial using a unique immunotherapeutic combination of MUC1-targeted CAR-T cells with PD-1-knockout in the treatment of patients with advanced esophageal cancer. Fruquintinib plus ...
Autofrettage is an established process in which controlled plastic deformation is induced in the inner layers of thick-walled cylinders to create beneficial compressive residual stresses. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results